Gentium S.p.A (GENT) Appoints Adrian Haigh as Senior Vice President, Commercial Operations
Gentium S.p.A. is adding a new member to its team. The company announced today that they have appointed Adrian Haigh as its Senior Vice President, Commercial Operations. Haigh will prepare the company and oversee the future commercial launch of Defibrotide, following regulatory approval. Regarding his future responsibilities, Haigh remarked, "I have been impressed by results obtained with Defibrotide to date and the reception the product has already received within the clinical community. More than 200 clinics across 30 countries have purchased Defibrotide through the Company's expanded access program. My priority is to quickly ensure that all patients with (or at…